Gary Khoo

With over 16 years of experience in biopharmaceuticals, Gary is a CMC strategy and operations leader with experience at leading cross functional CMC programs, external/internal manufacturing product technology transfer and process development programs. Gary previously held leadership and research roles at various large pharmaceutical and biotech companies, such as Tessa Therapeutics, Takeda, Baxter Bioscience, A-Biopharma (currently Luye Pharma), UCB Celltech, and A*STAR Bioprocessing Technology Institute. From his long-spanning career in biomedical manufacturing, he has amassed expertise across modalities including antibodies/recombinant proteins, recombinant virus products and cell/gene therapies.

Gary holds a PhD in Chemical Engineering (Biochemical Engineering) from the University of Birmingham.